AVGO
Broadcom
-- 224.010 NVDA
NVIDIA
-- 134.834 TSLA
Tesla
-- 432.600 AMD
Advanced Micro Devices
-- 126.260 PLTR
Palantir
-- 74.776 
Update
$Elevation Oncology (ELEV.US)$ Elevation Oncology Announced New Preclinical Data Demonstrating The Combination Potential Of EO-3021, A Claudin 18.2 Antibody-drug Conjugate, With VEGFR2 or PD-1 Inhibitors, The Data Will Be Presented At The European Society For Medical Oncology Immuno-oncology Annual Congress 2024
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment